Fluorescence Guided Resection and Photodynamic Therapy in Meningiomas
Meningiomas represent 30% of all intracranial neoplasms. They are predominantly slow growing extra axial brain tumours arising from arachnoidal cells and usually have an excellent prognosis if completely removed. However, radical tumour removal near vital functional structures and areas of infiltration is not always possible and histologically “benign” meningiomas may exhibit aggressive behaviour like infiltration and early recurrence. Biological markers that would make areas of infiltration visible by fluorescence might therefore have a significant impact on patient survival and quality of life.
5-Aminolevulinic acid (5-ALA) is a precursor in the cellular heme biosynthesis. The application of exogenous 5-ALA leads to an intracellular accumulation of protoporphyrin IX (PpIX), causing these PpIX saturated cells to become fluorescent and photosensitive under light of an appropriate wavelength. 5-ALA induced PpIX fluorescence has the ability to define infiltration zones into dural structures and bone and mark residual meningioma tissue. It has the potential to facilitate meningioma resection and to individualize the extent of dural resection for each patient in order to prevent morbidity.
Specific intracellular accumulation of PpIX can be used for photodynamic therapy (PDT). Induction of selective apoptosis, reduction of tumour vessel density and no risk of secondary carcinogenesis make PDT an ideal treatment option for meningiomas. Due to the variable potentials for PpIX accumulation within different meningioma subtypes, further research is required to ensure sufficiently intense fluorescence to enable PDT in these cases.
KeywordsMeningioma Cell Bone Invasion Benign Meningioma Simpson Grade Anaplastic Meningioma
- Fisher AM, Murphree AL, Gomer CJ (1995) 1995 clinical and preclinical photodynamic therapy. Lasers Surg Med 17(1):2–31Google Scholar
- Hefti M (2011) Comment concerning: intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas, Acta Neurochir DOl 1O.1007/s00701-010-0708-4, Intratumoral heterogeneity and fluorescence intensity in meningioma after 5-ALA pretreatment. Acta Neurochir 153(4):959–960CrossRefPubMedGoogle Scholar
- Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14:275–292Google Scholar
- Kostron H et al (2010) Photodynamic diagnosis and therapy and the brain. In: Charles J (ed) Photodynamic therapy: methods and protocols. Humana Press Springer, New YorkGoogle Scholar
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109Google Scholar
- Philippon J, Cornu P (1991) The recurrence of meningiomas. In: Al-Mefty O (ed) Meningiomas. Raven, New York, pp 87–106Google Scholar
- Sayaguès JM, Tabernero MD, MaÌllo A, Espinosa A, Rasillo A, Diaz P, Ciudad J, Lupez A, Merino M, Gonalves JM, Santos-Briz A, Morales F, Orfao A (2004) Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? J Mol Diagn 6(4):316–325PubMedCentralCrossRefPubMedGoogle Scholar